Concepedia

Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2

Florencia Rammauro, Federico Carrión, Natalia Olivero‐Deibe, Martín Fló, Ana Ferreira, Otto Pritsch, Sergio Bianchi

Vaccine · 2022 · 13 citations · 37 references

DOIFull text

Open access

Concepts

References

37

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.5K citations · Full text

, , +17

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury, Deborah Cromer, Arnold Reynaldi et al. · Nature Medicine · 2021 · 4.2K citations · Full text

, , +16

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

New England Journal of Medicine · 2021 · 1.8K citations · Full text

, , +17

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

New England Journal of Medicine · 2021 · 1.6K citations · Full text

, , +17

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

, , +17